University of Pennsylvania Medical Center
7th Floor Rhoads Pavillion
3400 Spruce Street
Philadelphia, PA 19104
Direct phone: (215) 662-3800
Total transplants by cell source
- Marrow: 48
- PBSC: 193
- Cord Blood: 16
- Autologous (PBSC or Marrow): 382
About the center
Transplants performed from related and unrelated donors using ablative and non-myeloablative conditioning, with marrow, blood stem cells and cord blood and Haplo transplants. Standard and investigational therapies available. Research focuses on improving safety, minimizing GVHD and enhancing graft-versus-tumor effect. We have treated over 170 patients with commercial car-T therapy since induction.
This center has been performing allogeneic transplants since 1996 and has been an NMDP/Be The Match transplant center since April 1999.
Adult - Daria Babushok, Adam Cohen, Noelle Frey, Alfred Garfall, Saar Gill, Elizabeth Hexner, Rebecca Hirsh, Daniel Landsburg, Alison Loren, Selina Luger, Mary Ellen Martin, Shannon McCurdy, Sunita Nasta, Alexander Perl, David Porter, Keith Pratz, Stephen Schuster, Edward Stadtmauer, Jakub Svoboda, Donal Tsai, Dan Vogl
Marrow/PBSC, single cord, and double cord
Cord blood transplants performed on
Other programs and services
Mental health counseling, Nutrition support, Financial grant help, Hope, Lodge accommodation help, Transportation, Advocacy, Financial help with medication costs, Support group, Home care help, Advance directive help.
Overall center survival
Patient survival information for this center
This center's actual 1-year survival results are similar to the expected rate for this center.
The survival information we have for this center includes ONLY:
- Patients who had their FIRST ALLOGENEIC transplant (cells from a related or unrelated donor/cord blood) during 2017, 2018, 2019, and
- Who had their transplant at a U.S. transplant center, and
- Who had follow-up information provided by the transplant center for analysis
For this center, we have survival information for 333 patients.
The actual 1-year survival of these patients is 75.1%.
Compared to similar patients transplanted at all centers in the U.S., we expect that the 1-year survival for patients at this center to be in a range between 69.2% and 78.3%.
For help with understanding these statistics, please see Understanding Transplant Outcomes.
For overall survival for all patients transplanted with a specific disease, please see U.S. Patient Survival report at bloodcell.transplant.hrsa.gov.
Transplants reported (From January 1, 2019 to December 31st, 2020 as reported by the centers)
|Both marrow & PBSC
Transplants by disease
Number of transplants by age reported from January 1, 2019 to December 31st, 2020 (includes marrow, PBSC and cord blood)
Treatments may be similar for diseases within a group. It might be helpful to look at centers that have done transplants for a specific disease and centers that have done transplants for any corresponding broad disease categories.
Centers are not required to report autologous transplants so the numbers might be incomplete.
More information about transplants for this disease can be found:
Transplant center resources
Transplant center coordinator:
Be The Match patient navigators
Patient navigators can answer your questions about choosing a transplant center and provide support and education to help you throughout your transplant journey.
Inside the United States: 1 (888) 999-6743
Outside the United States: 1 (763) 406-3410.
(Long distance or international charges may apply.)